AMRN
Amarin Corp. Plc
NASDAQ · Healthcare · Biotechnology · IE
$13.63
−1.73%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $43.8M
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.01
- Revenue actual
- $42.2M
- Revenue estimate
- $44.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -322.9%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | -$0.01 | -$0.02 | Miss -100.00% | $42.2M |
| Apr 29, 2026 | $0.01 | -$0.09 | Miss -1000.00% | $45.1M |
| Feb 25, 2026 | $0.07 | -$0.00 | Miss -104.20% | $19.4M |
| Oct 29, 2025 | $0.08 | $0.01 | Miss -87.50% | $48.6M |
| Jul 30, 2025 | -$0.66 | -$0.03 | Beat 95.45% | $46.6M |
| Mar 12, 2025 | -$1.20 | -$2.40 | Miss -100.00% | $62.3M |
| Jul 31, 2024 | $0.10 | $0.20 | Beat 100.00% | $67.6M |
| May 1, 2024 | -$0.80 | -$0.20 | Beat 75.00% | $56.5M |
| Feb 29, 2024 | -$0.01 | -$0.01 | Miss -66.67% | $75.4M |
| Nov 1, 2023 | -$0.04 | -$0.05 | Miss -11.11% | $66.1M |
| Aug 2, 2023 | -$0.40 | $0.40 | Beat 200.00% | $80.2M |
| May 3, 2023 | -$0.20 | $0.40 | Beat 300.00% | $86.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026